GlassScriptPhysician profile
Kevin Wess
NPI 1316061526
$574.89
in general payments reported to CMS, 2019-2025
12 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $30.36 · 2021: $60.29 · 2022: $94.96 · 2023: $85.39 · 2024: $41.04 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $139.06 | 2019-2021 | |
| Abbvie INC. | $81.90 | 2024-2025 | |
| Organogenesis INC. | $62.66 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Astrazeneca Pharmaceuticals LP | $61.72 | 2019-2021 | |
| Medline Industries LP | $50.76 | 2022 | |
| Molnlycke Health Care US, LLC | $49.15 | 2022-2023 | Mepilex Border Sacrum, Mlnlycke Z-Flex Fluidized Heel Boot, Mepilex Border Flex |
| Kci USA, INC. | $46.98 | 2022-2023 | Tegaderm |
| Reapplix INC. | $28.78 | 2025 | 3c Patch Kit - Box |
| Solventum Corporation | $15.27 | 2025 | Activ.A.C. |
| Polymedics Innovations INC. | $13.98 | 2023 | |
| Advanced Oxygen Therapy INC. | $13.06 | 2025 | Topical Oxygen Chamber For Extremities |
| Glaxosmithkline, LLC. | $11.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Wess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.